Ashleigh Barreto | Director, Corporate Communications & IR |
Gregory Went | Founder, Chairman and CEO |
Alfred Merriweather | CFO |
Richard King | COO |
Rajiv Patni | Chief Medical Officer |
Josh Schimmer | Evercore ISI |
David Amsellem | Piper Jaffray |
Tazeen Ahmad | Bank of America |
Ken Cacciatore | Cowen and Company |
Myles Minter | William Blair |
Irina Koffler | Mizuho |
Jason Butler | JMP Securities |
Serge Belanger | Needham and Company |
Ram Selvaraju | H.C. Wainwright |
Welcome to the Adamas Pharmaceuticals' Second Quarter 2018 Financial Results and Corporate Update Conference Call. [Operator Instructions] As a reminder, this call is being recorded. I would now like to turn over the call to your host, Ashleigh Barreto, Director of Investor Relations and Corporate Communications at Adamas. Please go ahead.
Thank you, Operator, and good afternoon, everyone.